- Home
- SEDG vs SLNO Comparison
SEDG vs SLNO Comparison
Compare SEDG & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SEDG | SLNO |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.3B |
| IPO Year | 2015 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SEDG | SLNO |
|---|---|---|
| Price | $40.44 | $52.72 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 20 | 9 |
| Target Price | $30.97 | ★ $83.00 |
| AVG Volume (30 Days) | 3.3M | ★ 6.2M |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 78.26 | ★ 108.90 |
| EPS | N/A | ★ 0.39 |
| Revenue | ★ $1,184,444,000.00 | $1,450,788.00 |
| Revenue This Year | $19.97 | $150.46 |
| Revenue Next Year | $13.79 | $50.37 |
| P/E Ratio | ★ N/A | $135.13 |
| Revenue Growth | 31.39 | ★ 138.82 |
| 52 Week Low | $11.45 | $29.43 |
| 52 Week High | $53.75 | $89.12 |
Technical Indicators
Market Signals| Indicator | SEDG | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 45.39 | 77.16 |
| Support Level | $30.35 | $48.91 |
| Resistance Level | $42.15 | $55.47 |
| Average True Range (ATR) | 3.47 | 0.72 |
| MACD | -1.02 | 0.63 |
| Stochastic Oscillator | 23.70 | 99.58 |
Price Performance
Historical ComparisonAbout SEDG SolarEdge Technologies Inc.
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.